Machine Learning Neuroprotective Strategy Reveals a Unique Set of Parkinson Therapeutic Nicotine Analogs

Translated title of the contribution: Machine Learning Neuroprotective Strategy Reveals a Unique Set of Parkinson Therapeutic Nicotine Analogs

Carlos Morantes Ariza

    Research output: Contribution to journalResearch Articlepeer-review

    Abstract

    Dopaminergic replacement has been used for Parkinson’s Disease (PD) treatment with positive effects on motor symptomatology but low progression and prevention effects. Epidemiological studies have shown that nicotine consumption decreases PD prevalence through neuroprotective mechanisms activation associated with the overstimulation of signaling pathways (SP) such as PI3K/AKT through nicotinic acetylcholine receptors (e.g α7 nAChRs) and over-expression of anti-apoptotic genes such as Bcl-2. Nicotine analogs with similar neuroprotective activity but decreased secondary effects remains as promissory field.
    Translated title of the contributionMachine Learning Neuroprotective Strategy Reveals a Unique Set of Parkinson Therapeutic Nicotine Analogs
    Original languageEnglish
    Article number1
    Pages (from-to)1-14
    Number of pages14
    JournalOpen Bioinformatics Journal
    Volume13
    Issue number1
    DOIs
    StatePublished - Mar 20 2020

    Fingerprint

    Dive into the research topics of 'Machine Learning Neuroprotective Strategy Reveals a Unique Set of Parkinson Therapeutic Nicotine Analogs'. Together they form a unique fingerprint.

    Cite this